comparemela.com

Latest Breaking News On - Orphazymea s - Page 1 : comparemela.com

New CEO appointed

As mentioned in announcement 11/2023 the Company and CEO/CFO Anders Fink Vadsholt entered into a severance agreement at May 30th 2023, where Mr. Vadsholt.

Anders fink vadsholtJakob bendtsenFink vadsholtMichael hoveCopenhagen stock exchange orphaOrphazymea s

Change in management

The board of directors and CEO/CFO Anders Fink Vadsholt has today entered into a severance agreement pursuant to which Mr. Vadsholt will step down as.

United statesAnders fink vadsholtFink vadsholtZevra therapeuticsPreviously kempharmMichael hoveCopenhagen stock exchange orphaOrphazymea s

Major shareholder announcement

Company announcement No. 10/2023 Orphazyme A/S Ole Maaløes Vej 3DK-2200 Copenhagen N www.orphazyme.comCompany Registration No. 32266355.

Company registration noScandinavian investment groupDanish capital markets actCopenhagen stock exchange orphaOrphazymea s

Change to Financial Calendar for 2023 and update regarding

Company announcement Orphazyme A/SNo. 01/2023 Ole Maaløes Vej.

United statesAnders vadsholtCompany registration noOrphazymeas orpha co orphazymeChief executive officerChief financial officerSecurities litigation reform actCopenhagen stock exchange orphaOrphazymea s

Adjusted financial outlook for 2022

Orphazyme A/SCompany announcement No. 35/2022 www.orphazyme.comCompany Registration No. 32266355 Copenhagen, Denmark,.

Anders vadsholtExchange commissionCompany annual report on formCompany sale of assetsCompany registration noChief executive officerChief financial officerPrivate securities litigation reform actRisk factorsAnnual reportCopenhagen stock exchange orphaOrphazymea s

vimarsana © 2020. All Rights Reserved.